We remain very optimistic for the oncology market and its players after attending the ASCO (American Society of Clinical Oncology) 2015 in Chicago, the world’s most important oncology congress.
Its annual meeting is the biggest and most important oncology conference throughout the year. More than 30000 attendees got updates on clinical trials, evolving science and just about everything else around oncology. Immunooncology (IO) was the key theme at the conference with very promising developments. However, new therapies are also needed for patients not responding to IO treatments.
What mattered this month in healthcare? The readout of the SELECT study was the single biggest healthcare event of the month. The results may open the door to wide reimbursement for GLP-1 weight-loss drugs. This led to an overreaction with significant price movements amongst many companies as markets just made blanket assumptions of a healthier, thinner world. Find out more in our monthly healthcare newsletter.
Remarkable Strides in Breast Cancer Survival: A Look at the Last Few Decades 🎗️📈 Intersted in knowing more? Check out Maria Specogna’s latest chart of the month video!
What mattered this month in healthcare? Second quarter earnings season kicked off to a strong start, with earnings overall better than estimates. However, positioning matters, and strong numbers were not always enough if expectations were high. Find out more in our monthly healthcare newsletter.